Salarius Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2014 to Q2 2024.
  • Salarius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.42M, a 63.3% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.46M, a 78.5% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 60.3% increase from 2022.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.6M, a 148% decline from 2021.
  • Salarius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.8M, a 73.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$6.46M -$1.42M +$2.45M +63.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$8.92M -$1.72M +$3.63M +67.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-09
Q4 2023 -$12.5M -$882K +$5.49M +86.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$18M -$2.44M +$12M +83% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$30M -$3.88M +$841K +17.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$30.8M -$5.34M +$768K +12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-09
Q4 2022 -$31.6M -$6.37M -$2.27M -55.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$29.3M -$14.4M -$10.7M -286% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$18.7M -$4.72M -$1.64M -53.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$17M -$6.11M -$4.26M -230% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$12.8M -$4.1M -$2.34M -132% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$10.4M -$3.74M -$2.02M -118% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$8.41M -$3.07M -$1.29M -72.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$7.12M -$1.85M +$232K +11.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$7.35M -$1.77M +$115K +6.12% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$7.47M -$1.72M +$911K +34.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$8.38M -$1.78M -$881K -97.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$7.5M -$2.08M -$562K -36.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$6.94M -$1.88M +$126K +6.27% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$7.06M -$2.63M -$2.32M -755% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$4.74M -$904K -$1.01M -912% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$3.73M -$1.52M -$1.14M -299% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$2.59M -$2.01M +$6.02M +75% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-06
Q3 2018 -$8.61M -$307K +$9.02M +96.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$17.6M $111K +$8.92M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$26.5M -$382K +$7.89M +95.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 -$34.4M -$8.03M -$128K -1.63% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$34.3M -$9.33M +$1.31M +12.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$35.6M -$8.8M +$2.56M +22.5% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$38.2M -$8.27M +$1.32M +13.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$39.5M -$7.9M -$7.23K -0.09% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$39.5M -$10.6M -$2.48M -30.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-07
Q2 2016 -$37M -$11.4M -$4.28M -60.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-07
Q1 2016 -$32.7M -$9.59M -$3.57M -59.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-07
Q4 2015 -$29.1M -$7.89M -$4.15M -111% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 -$25M -$8.15M -$6.17M -310% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-08
Q2 2015 -$18.8M -$7.08M -$4.89M -223% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-08
Q1 2015 -$13.9M -$6.02M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-08
Q4 2014 -$3.74M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$1.99M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-08
Q2 2014 -$2.19M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.